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The past few years have witnessed encouraging progress in
improving the methodological quality of clinical research of
traditional Chinese medicine (TCM). This improvement has
contributed to wider academic acceptance of the findings
of TCM clinical studies, which were previously deemed
dubious. As a proof of this statement, one clinical study
testing the effects of a Chinese patent drug Qili Qiangxin
Capsules on chronic heart failure has just published a research
article on the Journal of the American College of Cardiology,
a medical journal of international prestige. However, a sound
and scientific design does not always see to its practicality
in the conduct of the study, and in fact we observed a
widening gap between the two elements. In this special issue,
we called for papers discussing efforts to bridge the gap
between scientific design and practical implementation of
clinical research with TCM.
In Y. Xing et al.’s review article, “The effects of Wenxin
Keli on P-wave dispersion and maintenance of sinus rhythm
in patients with paroxysmal atrial fibrillation: a meta-analysis
of randomized controlled trials,” they synthesized and assessed
the results of randomized controlled trials (RCTs) in order to
address a specific clinical question and critically commented
on several practical issues in the conduct of TCM clinical
research.
In another review article, “Clinical research of traditional
Chinese medicine needs to develop its own system of core
outcome sets,” L. Zhang et al. proposed constructing a system
of core outcome sets that caters for clinical evaluation of TCM
after reviewing existing problems in the choice of outcomes
to be assessed in a clinical study.
Patient value is one of the three components necessary
for evidence-based clinical decision-making. Patient values
and its various manifestations also have a crucial role to play
in the conduct of a clinical research and in the evaluation
of TCM efficacy and safety. W. Mu and H. Shang called for
academic attention to this area of research in their paper
entitled “Understanding patient values and the manifestations
in clinical research with traditional Chinese medicine—with
practical suggestions for trial design and implementation.”
Issues around compliance control in clinical research of
TCM always attract interests. W. Zheng et al. summarized
practical barriers to the management of incompliant behav-
iors from past experiences of being a clinical trial investigator
and put up with point-to-point solutions in their review
article entitled “Improving participant adherence in clinical
research of traditional Chinese medicine.”
In H. Yu et al.’s research article “Clinical study on the
prevention of oxaliplatin-induced neurotoxicity with Guilong-
tongluofang: results of a randomized, double-blind, placebo-
controlled Trial,” they introduced the measures they took to
balance the rigorousness of study design and its practicality
and provided a successful example.
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In a similar vein, J. Pu et al. explained in the research
article “Chinese medicine Shensongyangxin is effective for
patients with bradycardia: results of a randomized, double-
blind, placebo-controlled multicenter trial” their experiences
of taking consideration of real clinical circumstances into
the process of trial design, so as to narrow the gap between
research design and implementation.
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